Capricor Therapeutics (CAPR) Change in Acquisitions & Divestments (2016 - 2025)
Capricor Therapeutics has reported Change in Acquisitions & Divestments over the past 12 years, most recently at $63.2 million for Q4 2025.
- Quarterly results put Change in Acquisitions & Divestments at $63.2 million for Q4 2025, up 278.14% from a year ago — trailing twelve months through Dec 2025 was $260.6 million (up 177.83% YoY), and the annual figure for FY2025 was $260.6 million, up 177.83%.
- Change in Acquisitions & Divestments for Q4 2025 was $63.2 million at Capricor Therapeutics, down from $78.2 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for CAPR hit a ceiling of $78.2 million in Q3 2025 and a floor of $14.0 million in Q2 2022.
- Median Change in Acquisitions & Divestments over the past 4 years was $30.1 million (2022), compared with a mean of $36.1 million.
- Biggest five-year swings in Change in Acquisitions & Divestments: plummeted 48.86% in 2023 and later surged 278.14% in 2025.
- Capricor Therapeutics' Change in Acquisitions & Divestments stood at $38.4 million in 2022, then crashed by 48.86% to $19.6 million in 2023, then fell by 14.89% to $16.7 million in 2024, then surged by 278.14% to $63.2 million in 2025.
- The last three reported values for Change in Acquisitions & Divestments were $63.2 million (Q4 2025), $78.2 million (Q3 2025), and $76.0 million (Q2 2025) per Business Quant data.